Erratum: Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB (Oncotarget (2012) 4 (362-372) DOI: 10.18632/oncotarget.901);Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB

Oncotarget

Volumn 4, Issue 2, 2013, Pages 362-372

  Aksenova, Vasilisa ^a,b   Turoverova, Lidia ^a   Khotin, Mikhai ^a   Magnusson, Karl Eric ^c   Tulchinsky, Eugene ^d   Melino, Gerry ^b,e   Pinaev, George P ^a   Barlev, Nickolai ^a,b,d   Tentler, Dmitri ^a,b  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b ST PETERSBURG STATE INSTITUTE OF TECHNOLOGY TECHNICAL UNIVERSITY   (Russian Federation)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

ACTN4; MMP; RelA p65; Transcription regulation

Indexed keywords

ALPHA ACTININ 4; F ACTIN; FIBROBLAST GROWTH FACTOR 8; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; PROTEIN BAX; PROTEIN C FOS; STROMELYSIN; TRANSCRIPTION FACTOR RELA;

ARTICLE; BAX GENE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DELETION MUTANT; FGF8 GENE; FN1 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; ICAM1 GENE; MMP 1 GENE; MMP 3 GENE; ONCOGENE C FOS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PTGS2 GENE; TNC GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 84875791595     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.901     Document Type: Erratum

References (60)

1. Honda K, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H, Yamada Y, Chiba H, Hirohashi S. Actinin-4, a novel actinbundling protein associated with cell motility and cancer invasion. J Cell Biol. 1998; 140: 1383-1393.
2. Jayadev R, Kuk CY, Low SH, Hori MM. Calcium sensitivity of a-actinin is required for equatorial actin assembly during cytokinesis. Cell Cycle. 2012; 11: 1929- 1937.
3. Gross SR. Actin binding proteins. Their ups and downs in metastatic life. Cell Adhes Migr; 2013; 7: dx.doi. org/10.4161/cam.23176.
4. Shao H, Wang JHC, Pollak MR, Wells A. a-Actinin-4 Is Essential for Maintaining the Spreading, Motility and Contractility of Fibroblasts. Plos One. 2010; 5: e13921.
5. Eckert MA, Yang J. Targeting invadopodia to block breast cancer metastasis. Oncotarget. 2011; 2: 562-568.
6. Djinovic-Carugo K, Gautel M, Ylanne J, Young P. The spectrin repeat: a structural platform for cytoskeletal protein assemblies. FEBS Letters. 2002; 513: 119-123.
7. Christerson LB, Vanderbilt CA, Cobb MH. MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions. Cell Motil Cytoskeleton. 1999; 43: 186- 198.
8. Gonzalez AM, Otey C, Edlund M, Jones JC. Interactions of hemidesmosome component and actinin family members. J Cell Sci. 2001; 114: 4197-4206.
9. Patrie KM, Drescher AJ, Welihinda A, Mundel P, Margolis B. Interaction of two actin binding proteins, synaptopodin and a-actinin-4, with the tight junction protein MAGI-1. J Biol Chem. 2002; 277: 30183-30190.
10. Broderick MJF, Winder SJ. Spectrin, a-actinin, and dystrophin. Adv Prot Chem. 2005; 70: 203-233.
11. Kumeta M, Yoshimura SH, Harata M, Takeyasu K. Molecular mechanisms underlying nucleocytoplasmic shuttling of actinin-4. J Cell Sci. 2010; 123: 1020-1030.
12. Poch MT, Al-Kassim L, Smolinski SM, Hines RN. Two distinct classes of CCAAT box elements that bind nuclear factor-Y/a-actinin-4: potential role in human CYP1A1 regulation. Toxicol App Pharmacol. 2004; 199: 239-250.
13. Liu QY, Lei JX, Blanc J Le, Sodja C, Ly D, Charlebois C, Walker PR, Yamada T, Hirohashi S, Sikorska M. Regulation of DNaseY activity by actinin-a4 during apoptosis. Cell Death Differ. 2004; 11: 645-654.
14. Babakov VN, Petukhova OA, Turoverova LV, Kropacheva IV, Tentler DG, Bolshakova AV, Podolskaya EP, Magnusson K-E, Pinaev GP. RelA/NF-kB transcription factor associates with a-actinin-4. Exper Cell Res. 2008; 314: 1030-1038.
15. Khotin M, Turoverova L, Aksenova V, Barlev N, Borutinskaite VV, Vener A, Bajenova O, Magnusson K-E, Pinaev G, Tentler D. Proteomic analysis of ACTN4- interacting proteins reveals it's a putative involvement in mRNA metabolism. Biochem Biophys Res Com. 2010; 397: 192-196.
16. Chakraborty S, Reineke EL, Lam M, Li X, Liu Y, Gao C, Khurana S, Kao HY. Alpha-actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7. J Biol Chem. 2006; 281: 35070- 35080.
17. Khurana S, Chakraborty S, Lam M, Liu Y, Su YT, Zhao X, Saleem MA, Mathieson PW, Bruggeman LA, Kao HY. Familial focal segmental glomerulosclerosis (FSGS)-linked a-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. J Biol Chem. 2012; 287: 12027-12035.
18. Khurana S, Chakraborty S, Zhao X, Liu Y, Guan D, Lam M, Huang W, Yang S, Kao HY. Identification of a novel LXXLL motif in a-actinin 4-spliced isoform that is critical for its interaction with estrogen receptor a and co-activators. J Biol Chem. 2012; 287: 35418-35429.
19. Dixit D, Sharma V, Ghosh S, Mehta VS, Sen E. Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFa)-induced apoptosis through SIRT1 inhibition. Cell Death Dis. 2012; 3: e271.
20. Walsby E, Pearce L, Burnett AK, Fegan C, Pepper C. The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-?B signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells. Oncotarget. 2012; 3: 525-34.
21. Chefetz I, Holmberg JC, Alvero AB, Visintin I, Mor G. Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NF?B pathway. Cell Cycle. 2011; 10: 2206-14.
22. Nogueira L, Ruiz-Ontañon P, Vazquez-Barquero A, Moris F, Fernandez-Luna JL. The NF?B pathway: a therapeutic target in glioblastoma. Oncotarget. 2011; 2: 646-53.
23. Markert EK, Levine AJ, Vazquez A. Proliferation and tissue remodeling in cancer: the hallmarks revisited. Cell Death Dis. 2012; 3: e397.
24. Vaughan S, Jat PS. Deciphering the role of nuclear factorkB in cellular senescence. Aging. 2011; 3: 913-9.
25. Hasler U. An example of functional interaction between NFAT5/TonEBP and nuclear factor-kB by hypertonic stress: aquaporin-2 transcription. Cell Cycle. 2011; 10: 364- 5.
26. Silke J, Vince JE. IAPs, TNF, inflammation and Jürg Tschopp; a personal perspective. Cell Death Differ. 2012; 19: 1-4.
27. Kim SY, Jeong S, Jung E, Baik KH, Chang MH, Kim SA, Shim JH, Chun E, Lee KY. AMP-activated protein kinase-a1 as an activating kinase of TGF-ß-activated kinase 1 has a key role in inflammatory signals. Cell Death Dis. 2012; 3: e357.
28. Papi A, Guarnieri T, Storci G, Santini D, Ceccarelli C, Taffurelli M, De Carolis S, Avenia N, Sanguinetti A, Sidoni A, Orlandi M, Bonafé M. Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells. Cell Death Differ. 2012; 7: 1208- 19.
29. Mora E, Guglielmotti A, Biondi G, Sassone-Corsi P. Bindarit: an anti-inflammatory small molecule that modulates the NF?B pathway. Cell Cycle. 2012; 11: 159- 69.
30. Bellet MM, Zocchi L, Sassone-Corsi P. The RelB subunit of NF?B acts as a negative regulator of circadian gene expression. Cell Cycle. 2012; 11: 3304-11.
31. Sandow JJ, Jabbour AM, Condina MR, Daunt CP, Stomski FC, Green BD, Riffkin CD, Hoffmann P, Guthridge MA, Silke J, Lopez AF, Ekert PG. Cytokine receptor signaling activates an IKK-dependent phosphorylation of PUMA to prevent cell death. Cell Death Differ. 2012; 19: 633-41.
32. Lippens S, Lefebvre S, Gilbert B, Sze M, Devos M, Verhelst K, Vereecke L, Mc Guire C, Guérin C, Vandenabeele P, Pasparakis M, Mikkola ML, Beyaert R, Declercq W, van Loo G. Keratinocyte-specific ablation of the NF-?B regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ. 2011; 18: 1845-53.
33. Saccani S. All p65-containing dimers are not equal. Cell Cycle. 2012; 11: 646-7.
34. Criollo A, Chereau F, Malik SA, Niso-Santano M, Mariño G, Galluzzi L, Maiuri MC, Baud V, Kroemer G. Autophagy is required for the activation of NF?B. Cell Cycle. 2012; 11: 194-9.
35. Moujalled DM, Cook WD, Lluis JM, Khan NR, Ahmed AU, Callus BA, Vaux DL. In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-?B, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-?B is required to prevent it. Cell Death Differ. 2012; 19: 808-15.
36. Rauert H, Stühmer T, Bargou R, Wajant H, Siegmund D. TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms. Cell Death Dis. 2011; 2: e194.
37. Fan YH, Yu Y, Mao RF, Tan XJ, Xu GF, Zhang H, Lu XB, Fu SB, Yang J. USP4 targets TAK1 to downregulate TNFa-induced NF-?B activation. Cell Death Differ. 2011; 18: 1547-60.
38. Vanlangenakker N, Bertrand MJ, Bogaert P, Vandenabeele P, Vanden Berghe T. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis. 2011; 2: e230.
39. Song S, Choi K, Ryu SW, Kang SW, Choi C. TRAIL promotes caspase-dependent pro-inflammatory responses via PKCd activation by vascular smooth muscle cells. Cell Death Dis. 2011; 2: e223.
40. Mange LA, May MJ. The NF-kB paradox: RelB induces and inhibits gene expression. Cell Cycle. 2011; 10: 6-7.
41. Ge R, Wang Z, Zeng Q, Xu X, Olumi AF. F-box protein 10, an NF-?B-dependent anti-apoptotic protein, regulates TRAIL-induced apoptosis through modulating c-Fos/c- FLIP pathway. Cell Death Differ. 2011; 18: 1184-95.
42. Janssens S, Tinel A. The PIDDosome, DNA-damageinduced apoptosis and beyond. Cell Death Differ. 2012; 19: 13-20.
43. Khandelwal N, Simpson J, Taylor G, Rafique S, Whitehouse A, Hiscox J, Stark LA. Nucleolar NF-?B/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin. Cell Death Differ. 2011; 18: 1889-903.
44. Shu G, Tang Y, Zhou Y, Wang C, Song JG. Zac1 is a histone acetylation-regulated NF-?B suppressor that mediates histone deacetylase inhibitor-induced apoptosis. Cell Death Differ. 2011; 18: 1825-35.
45. Heinz LX, Rebsamen M, Rossi DC, Staehli F, Schroder K, Quadroni M, Gross O, Schneider P, Tschopp J. The death domain-containing protein Unc5CL is a novel MyD88- independent activator of the pro-inflammatory IRAK signaling cascade. Cell Death Differ. 2012; 19: 722-31.
46. Darding M, Meier P. IAPs: guardians of RIPK1. Cell Death Differ. 2012; 19: 58-66.
47. Hayden MS, Goch S. Signaling to NF-kappaB. Genes Dev. 2004; 18: 2195-2224.
48. Are AF, Galkin VE, Pospelova TV, Pinaev GP. The p65/ RelA subunit of NFkappaB interacts with actin-containing structures. Exp Cell Res. 2000; 256: 533-544.
49. Saksela K, Baltimore D. Negative Regulation of Immunoglobulin Kappa Light-Chain Gene Transcription by a Short Sequence Homologous to the Murine Bi Repetitive Element. Mol Cell Biol. 1993; 13: 3698-3705.
50. Kohman A, Kammere U, Kapp M, Dietl J, Anacker J. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature. BMC Cancer. 2009; doi: 10.1186/1471-2407-9-188.
51. Alge-Prigliner CS, Kreutzer T, Obholzer K, Wolf A, Mempl M, Kernt M, Kampik A, Priglinger SG. Oxidative Stress- Mediated Induction of MMP-1 and MMP-3 in Human RPE Cells. Inv Ophtalmol Vis Sci. 2009; 50: 5495-5503.
52. Bond M, Chase AJ, Baker AH, Newby AC. Inhibition of transcription factor NF-kB reduces matrix metalloproteinase-1, -3, and -9 production by vascular smooth muscle cells. Cardiovasc Res. 2001; 50: 556-565.
53. Chen J-H, Lin H-H, Chiang T-A, Hsu J-D, Ho H-H, Lee Y-C, Wang C-J. Gaseous Nitrogen Oxide Promotes Human Lung Cancer Cell Line A549 Migration, Invasion, and Metastasis via iNOS-Mediated MMP-2 Production. Toxicol Sci. 2008; 106: 364-375.
54. Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-kB. Cell Death Differ. 2006; 13: 759-772.
55. Mattson MP, Meffert MK. Roles for NF-kB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006; 13: 852-860.
56. Lanzillotta A, Sarnico I, Ingrassia R, Boroni F, Branca C, Benarese M, Faraco G, Blasi F, Chiarugi A, Spano P, Pizzi M. The acetylation of RelA in Lys310 dictates the NF-?Bdependent response in post-ischemicinjury. Cell Death Dis. 2010; 12: e107.
57. Manna SK, Manna P, Sarkar A. Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NFkappaB- expressing and chemoresistant cells. Cell Death Differ. 2007; 14: 158-170.
58. Park C-H, Lee MJ, Ahn J, Kim S, Kim HH, Kim KH, Eun HC, Chung JH. Heat Shock-Induced Matrix Metalloproteinase (MMP)-1 and MMP-3 Are Mediated through ERK and JNK Activation and via an Autocrine Interleukin-6 Loop. J Invest Dermatol. 2004; 123: 1012- 1019.
59. Yu H, Li Z, Ghosh D, Lim TK, He Y, Lin Q. a-Actinin4 nuclear translocation mediates gonadotropin-releasing hormone stimulation of follicle-stimulating hormone ß-subunit gene transcription in LßT2 cells. FEBS Letters. 2012; 586: 1466-71.
60. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979; 76: 4350-4354.